The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 07, 2020
Filed:
Apr. 26, 2019
Applicant:
Kaleido Biosciences, Inc., Lexington, MA (US);
Inventors:
Geoffrey A. von Maltzahn, Somerville, MA (US);
Jared Silverman, Brookline, MA (US);
Yvonne J. Yamanaka, Cambridge, MA (US);
John Miles Milwid, Winchester, MA (US);
John M. Geremia, Watertown, MA (US);
Assignee:
KALEIDO BIOSCIENCES, INC., Lexington, MA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/702 (2006.01); A61K 45/06 (2006.01); A61K 31/716 (2006.01); A61K 31/733 (2006.01); A61P 1/00 (2006.01); A61K 31/09 (2006.01); A61K 31/11 (2006.01); A61K 31/12 (2006.01); A61K 31/165 (2006.01); A61K 31/34 (2006.01); A61K 31/353 (2006.01); A61K 31/365 (2006.01); A61K 31/366 (2006.01); A61K 31/7034 (2006.01); A61K 31/7048 (2006.01); A61K 31/706 (2006.01); A61K 31/715 (2006.01); A23L 33/10 (2016.01); A23P 10/00 (2016.01); A61K 31/7004 (2006.01); A61K 31/7016 (2006.01); A61K 35/741 (2015.01); A61K 35/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/702 (2013.01); A23L 33/10 (2016.08); A23P 10/00 (2016.08); A61K 31/09 (2013.01); A61K 31/11 (2013.01); A61K 31/12 (2013.01); A61K 31/165 (2013.01); A61K 31/34 (2013.01); A61K 31/353 (2013.01); A61K 31/365 (2013.01); A61K 31/366 (2013.01); A61K 31/7004 (2013.01); A61K 31/706 (2013.01); A61K 31/7016 (2013.01); A61K 31/7034 (2013.01); A61K 31/7048 (2013.01); A61K 31/715 (2013.01); A61K 31/716 (2013.01); A61K 31/733 (2013.01); A61K 35/741 (2013.01); A61K 45/06 (2013.01); A61P 1/00 (2018.01); A23V 2002/00 (2013.01); A61K 2035/115 (2013.01); Y02A 50/475 (2018.01); Y02A 50/481 (2018.01);
Abstract
Preparations of glycan therapeutics, pharmaceutical compositions and medical foods thereof, optionally comprising micronutrients, polyphenols, prebiotics, probiotics, or other agents are provided and methods of making same. Also provided are methods of using said glycan therapeutics, e.g. for the modulation of human gastrointestinal microbiota and to treat dysbioses.